Published in Telemedicine Law Weekly, January 13th, 2007
This trend article about University of Pittsburgh, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Current study results from the report, "Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells," have been published. "Alpha-synuclein is a presynaptic protein strongly implicated in Parkinson's disease (PD). Because dopamine neurons are invariably compromised during pathogenesis in PD, we have been exploring the functions of alpha-synuclein with particular relevance to dopaminergic neuronal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.